Gene
SLC4A2
solute carrier family 4 member 2
Explore in graph →CI-GENE-00030793HGNC:11028 ENSG00000164889 NCBI 6522 Approved
Curated evidence
Clinical evidence (0)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
Data not yet available
No curated evidence item involves this gene yet.
Cohorts
Alteration frequency by cohort (3)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
gdcProvenance
- Source
- NCI Genomic Data Commons (open aggregated data)
- Dataset
- GDC top mutated genes by project
- Version
- Data Release 46.0
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- Open-access GDC data (NCI); citation of GDC and originating program requested
- Run
- ING-GDC-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Refractory Cancers (RC) - Peripheral T-Cell Lymphoma (PTCL) RC-PTCL | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Ssm | 15 | 58 | 25.9% | 66 | gdc |
| Metastatic Triple Negative Breast Cancer (UNC Phase II Trial, J Immunother Cancer 2022) - iAtlas Harmonized brca_iatlas_anders_2022 | Invasive Breast Carcinoma | Ssm | 3 | 25 | 12% | 159 | cbioportal |
| Metastatic Breast Cancer (AURORA US Network, Nat Cancer 2023) brca_aurora_2023 | Invasive Breast Carcinoma | Ssm | 14 | 134 | 10.4% | 155 | cbioportal |
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.